Literature DB >> 30635988

The Canadian Dementia Imaging Protocol: Harmonizing National Cohorts.

Simon Duchesne1,2, Isabelle Chouinard2, Olivier Potvin2, Vladimir S Fonov3, April Khademi4, Robert Bartha5, Pierre Bellec6, D Louis Collins3, Maxime Descoteaux7, Rick Hoge3, Cheryl R McCreary8, Joel Ramirez9, Christopher J M Scott9, Eric E Smith8, Stephen C Strother10, Sandra E Black9.   

Abstract

BACKGROUND: Harmonized protocols to collect imaging data must be devised, employed, and maintained in multicentric studies to reduce interscanner variability in subsequent analyses.
PURPOSE: To present a standardized protocol for multicentric research on dementia linked to neurodegeneration in aging, harmonized on all three major vendor platforms. The protocol includes a common procedure for qualification, quality control, and quality assurance and feasibility in large-scale studies. STUDY TYPE: Prospective.
SUBJECTS: The study involved a geometric phantom, a single individual volunteer, and 143 cognitively healthy, mild cognitively impaired, and Alzheimer's disease participants in a large-scale, multicentric study. FIELD STRENGTH/SEQUENCES: MRI was perform with 3T scanners (GE, Philips, Siemens) and included 3D T1 w, PD/T2 w, T 2 * , T2 w-FLAIR, diffusion, and BOLD resting state acquisitions. ASSESSMENT: Measures included signal- and contrast-to-noise ratios (SNR and CNR, respectively), total brain volumes, and total scan time. STATISTICAL TESTS: SNR, CNR, and scan time were compared between scanner vendors using analysis of variance (ANOVA) and Tukey tests, while brain volumes were tested using linear mixed models.
RESULTS: Geometric phantom T1 w SNR was significantly (P < 0.001) higher in Philips (mean: 71.4) than Siemens (29.5), while no significant difference was observed between vendors for T2 w (32.0 and 37.2, respectively, P = 0.243). Single individual volunteer T1 w CNR was higher in subcortical regions for Siemens (P < 0.001), while Philips had higher cortical CNR (P =  0.044). No significant difference in brain volumes was observed between vendors (P = 0.310/0.582/0.055). The average scan time was 41.0 minutes (SD: 2.8) and was not significantly different between sites (P = 0.071) and cognitive groups (P = 0.853). DATA
CONCLUSION: The harmonized Canadian Dementia Imaging Protocol suits the needs of studies that need to ensure quality MRI data acquisition for the measurement of brain changes across adulthood, due to aging, neurodegeneration, and other etiologies. A detailed description, exam cards, and operators' manual are freely available at the following site: www.cdip-pcid.ca. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:456-465.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  diffusion tensor imaging; magnetic resonance imaging; morphometry; neuroimaging; resting state functional MRI; standardization

Mesh:

Year:  2018        PMID: 30635988     DOI: 10.1002/jmri.26197

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  18 in total

Review 1.  Defining Individual-Specific Functional Neuroanatomy for Precision Psychiatry.

Authors:  Caterina Gratton; Brian T Kraus; Deanna J Greene; Evan M Gordon; Timothy O Laumann; Steven M Nelson; Nico U F Dosenbach; Steven E Petersen
Journal:  Biol Psychiatry       Date:  2019-11-07       Impact factor: 13.382

2.  A longitudinal multi-scanner multimodal human neuroimaging dataset.

Authors:  Colin Hawco; Erin W Dickie; Gabrielle Herman; Jessica A Turner; Miklos Argyelan; Anil K Malhotra; Robert W Buchanan; Aristotle N Voineskos
Journal:  Sci Data       Date:  2022-06-14       Impact factor: 8.501

3.  Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases.

Authors:  Miracle Ozzoude; Brenda Varriano; Derek Beaton; Joel Ramirez; Melissa F Holmes; Christopher J M Scott; Fuqiang Gao; Kelly M Sunderland; Paula McLaughlin; Jennifer Rabin; Maged Goubran; Donna Kwan; Angela Roberts; Robert Bartha; Sean Symons; Brian Tan; Richard H Swartz; Agessandro Abrahao; Gustavo Saposnik; Mario Masellis; Anthony E Lang; Connie Marras; Lorne Zinman; Christen Shoesmith; Michael Borrie; Corinne E Fischer; Andrew Frank; Morris Freedman; Manuel Montero-Odasso; Sanjeev Kumar; Stephen Pasternak; Stephen C Strother; Bruce G Pollock; Tarek K Rajji; Dallas Seitz; David F Tang-Wai; John Turnbull; Dar Dowlatshahi; Ayman Hassan; Leanne Casaubon; Jennifer Mandzia; Demetrios Sahlas; David P Breen; David Grimes; Mandar Jog; Thomas D L Steeves; Stephen R Arnott; Sandra E Black; Elizabeth Finger; Maria Carmela Tartaglia
Journal:  Geroscience       Date:  2022-03-16       Impact factor: 7.581

4.  Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease.

Authors:  Ibrahim Shaikh; Christian Beaulieu; Myrlene Gee; Cheryl R McCreary; Andrew E Beaudin; Diana Valdés-Cabrera; Eric E Smith; Richard Camicioli
Journal:  Neuroimage Clin       Date:  2022-04-04       Impact factor: 4.891

5.  Reproducibility of Structural and Diffusion Tensor Imaging in the TACERN Multi-Center Study.

Authors:  Anna K Prohl; Benoit Scherrer; Xavier Tomas-Fernandez; Rajna Filip-Dhima; Kush Kapur; Clemente Velasco-Annis; Sean Clancy; Erin Carmody; Meghan Dean; Molly Valle; Sanjay P Prabhu; Jurriaan M Peters; E Martina Bebin; Darcy A Krueger; Hope Northrup; Joyce Y Wu; Mustafa Sahin; Simon K Warfield
Journal:  Front Integr Neurosci       Date:  2019-07-17

6.  The Canadian Dementia Imaging Protocol: Harmonization validity for morphometry measurements.

Authors:  Olivier Potvin; Isabelle Chouinard; Louis Dieumegarde; Robert Bartha; Pierre Bellec; D Louis Collins; Maxime Descoteaux; Rick Hoge; Joel Ramirez; Christopher J M Scott; Eric E Smith; Stephen C Strother; Sandra E Black; Simon Duchesne
Journal:  Neuroimage Clin       Date:  2019-07-18       Impact factor: 4.881

Review 7.  Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases.

Authors:  Christopher G Schwarz
Journal:  Neurotherapeutics       Date:  2021-03-15       Impact factor: 7.620

8.  Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.

Authors:  Arunima Kapoor; Robert Bartha; Sandra E Black; Michael Borrie; Morris Freedman; Fuqiang Gao; Nathan Herrmann; Jennifer Mandzia; Miracle Ozzoude; Joel Ramirez; Christopher J M Scott; Sean Symons; Corinne E Fischer; Andrew Frank; Dallas Seitz; Michael Uri Wolf; Nicolaas Paul L G Verhoeff; Gary Naglie; William Reichman; Mario Masellis; Sara B Mitchell; David F Tang-Wai; Maria Carmela Tartaglia; Sanjeev Kumar; Bruce G Pollock; Tarek K Rajji; Elizabeth Finger; Stephen H Pasternak; Richard H Swartz
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 9.  Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.

Authors:  Eric E Smith; Geert Jan Biessels; François De Guio; Frank Erik de Leeuw; Simon Duchesne; Marco Düring; Richard Frayne; M Arfan Ikram; Eric Jouvent; Bradley J MacIntosh; Michael J Thrippleton; Meike W Vernooij; Hieab Adams; Walter H Backes; Lucia Ballerini; Sandra E Black; Christopher Chen; Rod Corriveau; Charles DeCarli; Steven M Greenberg; M Edip Gurol; Michael Ingrisch; Dominic Job; Bonnie Y K Lam; Lenore J Launer; Jennifer Linn; Cheryl R McCreary; Vincent C T Mok; Leonardo Pantoni; G Bruce Pike; Joel Ramirez; Yael D Reijmer; Jose Rafael Romero; Stefan Ropele; Natalia S Rost; Perminder S Sachdev; Christopher J M Scott; Sudha Seshadri; Mukul Sharma; Steven Sourbron; Rebecca M E Steketee; Richard H Swartz; Robert van Oostenbrugge; Matthias van Osch; Sanneke van Rooden; Anand Viswanathan; David Werring; Martin Dichgans; Joanna M Wardlaw
Journal:  Alzheimers Dement (Amst)       Date:  2019-02-26

10.  Influence of equipment changes on MRI measures of brain atrophy and brain microstructure in a placebo-controlled trial of ibudilast in progressive multiple sclerosis.

Authors:  Ken Sakaie; Janel K Fedler; Jon W Yankey; Kunio Nakamura; Josef Debbins; Mark J Lowe; Paola Raska; Robert J Fox
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.